Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00201019
Status:
COMPLETED
Last Update Posted:
2015-12-02
First Post:
2005-09-12
Brief Title:
Improving Adherence to Blood Pressure Guidelines
Sponsor:
University of Iowa
Organization:
University of Iowa
Study Overview
Official Title:
Improving Adherence to Blood Pressure Guidelines
Status:
COMPLETED
Status Verified Date:
2015-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the impact of physicianpharmacist collaborative teams on hypertension guideline adherence for patients with uncontrolled hypertension in six family medicine practice sites in Iowa
Detailed Description:
BACKGROUND
Hypertension is a prevalent chronic condition that if left untreated can lead to significant cardiovascular morbidity and premature mortality There are established evidence-based guidelines for the treatment of hypertension However these guidelines are not routinely adhered to by all providers for reasons that are not well known or understood In addition inadequate control of BP nationwide has been well documented This study will explore barriers to guideline adherence Phase I and evaluate via a randomized controlled trial a new approach to enhancing guideline adherence and ultimately BP control
DESIGN NARRATIVE
The long-range goal of the principal investigator is to develop and evaluate collaborative relationships between physicians and pharmacists that improve pharmacotherapy This will be a 5-year multicenter study to evaluate the impact of physicianpharmacist collaborative teams on adherence to hypertension guidelines JNC-VI in six community-based family practice sites There will be two study phases Phase I comprises a needs assessment to identify barriers to guideline adherence and design intervention implementation refinement strategies Phase II will be a prospective randomized trial to assess the impact of physicianpharmacist collaborative teams on hypertension guideline adherence and BP control The specific aims of Phase I are 1 to identify the scope and nature of physician and patient variables that may contribute to poor guideline adherence and 2 to refine the intervention implementation strategy and design tools for assessing guideline adherence and barriers to adherence The specific aims of Phase II are 1 to determine if there is a change in guideline adherence and knowledge of hypertension when physicians are involved in physicianpharmacist teams and 2 to determine if physicianpharmacist teams can achieve better BP control compared to usual care The investigators expect that the improvement in guideline adherence and reduction in BP with this intervention will significantly impact patients with hypertension Because there are more than 37 million Americans with uncontrolled hypertension this model has the potential to become an important strategy to help achieve the BP goals for Healthy People 2010
Hypertension is a prevalent chronic condition that if left untreated can lead to significant cardiovascular morbidity and premature mortality There are established evidence-based guidelines for the treatment of hypertension However these guidelines are not routinely adhered to by all providers for reasons that are not well known or understood In addition inadequate control of BP nationwide has been well documented This study will explore barriers to guideline adherence Phase I and evaluate via a randomized controlled trial a new approach to enhancing guideline adherence and ultimately BP control
DESIGN NARRATIVE
The long-range goal of the principal investigator is to develop and evaluate collaborative relationships between physicians and pharmacists that improve pharmacotherapy This will be a 5-year multicenter study to evaluate the impact of physicianpharmacist collaborative teams on adherence to hypertension guidelines JNC-VI in six community-based family practice sites There will be two study phases Phase I comprises a needs assessment to identify barriers to guideline adherence and design intervention implementation refinement strategies Phase II will be a prospective randomized trial to assess the impact of physicianpharmacist collaborative teams on hypertension guideline adherence and BP control The specific aims of Phase I are 1 to identify the scope and nature of physician and patient variables that may contribute to poor guideline adherence and 2 to refine the intervention implementation strategy and design tools for assessing guideline adherence and barriers to adherence The specific aims of Phase II are 1 to determine if there is a change in guideline adherence and knowledge of hypertension when physicians are involved in physicianpharmacist teams and 2 to determine if physicianpharmacist teams can achieve better BP control compared to usual care The investigators expect that the improvement in guideline adherence and reduction in BP with this intervention will significantly impact patients with hypertension Because there are more than 37 million Americans with uncontrolled hypertension this model has the potential to become an important strategy to help achieve the BP goals for Healthy People 2010
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01HL070740 | NIH | None | httpsreporternihgovquickSearchR01HL070740 |